Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 35,275 | 26,976 | 14,463 | 11,697 | 10,390 |
| Gross Profit | 35,275 | 26,976 | 14,463 | 11,697 | 10,390 |
| Operating Expenses | 245,147 | 216,922 | 131,116 | 77,315 | 62,350 |
| Operating Income | -209,872 | -189,946 | -116,653 | -65,618 | -51,960 |
| Interest Expense | 1,730 | 3,263 | 3,344 | 2,984 | 457 |
| Other Income | 37,806 | 14,002 | 5,756 | 120 | 683 |
| Pre-tax Income | -173,796 | -179,207 | -114,241 | -68,482 | -51,734 |
| Income Tax | -4,765 | 1,457 | -1,524 | -1,663 | -724 |
| Net Income Continuous | -169,031 | -180,664 | -112,717 | -66,819 | -51,010 |
| Net Income | $-169,031 | $-180,664 | $-112,717 | $-66,819 | $-51,010 |
| EPS Basic Total Ops | -2.90 | -5.08 | -3.80 | -2.67 | -2.66 |
| EPS Basic Continuous Ops | -2.90 | -5.08 | -3.80 | -2.67 | -2.66 |
| EPS Diluted Total Ops | -2.90 | -5.08 | -3.80 | -2.67 | -2.66 |
| EPS Diluted Continuous Ops | -2.90 | -5.08 | -3.80 | -2.67 | -2.66 |
| EPS Diluted Before Non-Recurring Items | -2.95 | -5.08 | -3.80 | -2.67 | -2.66 |
| EBITDA(a) | $-202,698 | $-183,400 | $-112,964 | $-64,209 | $-50,683 |